Asper Biogene LLC

22/12/2025

As we reflect on this holiday of peace, love and compassion we stand with Ukraine and all who defend freedom and human dignity.
Thank you for your partnership, and we look forward to the year ahead.
Merry Christmas and Happy New Year!🎄

17/11/2024

🎉We have updated our Metabolic Disorders & Cardiogenetics test panels!🎉
Updates involve the FTAAD gene panel with genes associated with Ehlers-Danlos syndrome.
The analysis of familial hypercholesterolaemia now includes 8 genes!👌
For more details visit: https://www.asperbio.com/

06/11/2023

Excitement is in the air at Asper Biogene as our CEO, Hardi Tamm, represents us in the ongoing Estonia-Kenya business collaboration in Nairobi! We're thrilled to showcase our advanced genetic testing solutions, covering over 2500 diseases across various medical specialties.

Amidst a distinguished delegation from Estonia, including Nortal, DocuMental, Better Medicine, SpeakTX, and Triumf Health, we eagerly look forward to engaging with industry leaders in Kenya. Our aim is to foster meaningful partnerships and drive innovation in the healthcare sector. We are excited to explore collaboration opportunities within the local healthcare community.

Find out more about the event and our fellow participants here: https://lnkd.in/eheDDTZ4

23/03/2022

We have updated several of our Neurogenetics and Metabolic diseases test panels including CMT, Leukodystrophy & Leukoencephalopathy, Hereditary Spastic Paraplegia and Metabolic Myopathy panels.

Learn more at
🟡 asperbio.com/asper-neurogenetics/
🟢 asperbio.com/asper-metabolic-disorders/

28/02/2022

Do you know that February 28th is the Rare Disease Day?
💚💙💜💗

Everyone is invited to light or decorate their home with the Rare Disease Day colours at 7 pm your local time on Monday, 28 February 2022. Monuments, offices, schools and homes are being lit up in the Rare Disease Day colours (green, blue, purple and pink) to raise awareness for the 300 million people living with a rare disease and their families.

Share your colours!
💚💙💜💗



Find more at https://www.rarediseaseday.org/

04/02/2022

The goal is simple: health equity now. The cancer care gap is not inevitable. Collectively, we can reduce inequity by:
✅ educating the public about cancer prevention;
✅ equipping healthcare professionals with skills and knowledge including about how inequity influences cancer care;
✅ strengthening primary health care delivered in communities;
✅ addressing through policy and programmes some of the social and economic factors that can negatively affect people’s health;
✅ increasing the resources – meaning both money and people – dedicated to cancer research, and tracking the burden of cancer nationally to more effectively shape our investments;
✅ implementing country-specific cancer prevention and control plans that address each country’s unique needs and resources.

An international awareness day led by the Union for International Cancer Control (UICC) to raise worldwide attention and inspire action for a cancer-free future.

02/02/2022

It was a great pleasure to discuss the latest changes and challenges in molecular diagnostics with other Estonian frontrunners of precision medicine. Thank you Stephan Goldbaum, Sven Parkel and Erki Mölder for sharing your thoughts and ideas in this fruitful panel discussion.
Also many thanks for Jaan Reinhold, Mazin Gadir, Roomer Tarajev, Ege Devon and members of the Estonian Health Tech delegation: Antegenes, Competence Centre on Health Technologies, DocuMental, The Institute of Genomics University of Tartu, Migrevention, Nordwise, Triumf Health, Solis Biodyne, Enterprise Estonia, Estonian Connected Health Cluster, Tartu Biotechnology Park, Smart City Tartu.

Eesti tervishoiu äridelegatsioon kohtus Dubai EXPO-l Araabia Ühendemiraatide (AÜE) tervishoiuministeeriumi ja Abu Dhabi terviseameti esindajatega, et arutada koostöövõimalusi. Kohtumised toimusid tervisetehnoloogia messide Arab Health ja Medlab 2022 raames, mille jooksul toimus EXPO Eesti pavi...

19/01/2022

Join us for business seminar discussing working solutions and case studies in tackling the challenges in modern molecular diagnostics.

20/12/2021

15/12/2021

Gene panels for cardiomyopathies and hyperlipidemias are just some selection of Asper Biogene genetic testing menu. Visit https://www.asperbio.com/asper-cardiogenetics/ to see the complete list of tests.

09/12/2021

Existing NGS panels are easily adjustable for your clinical practice and patients’ indications. Visit https://www.asperbio.com/asper-cardiogenetics/ to learn more!

17/11/2021

November is Lung Cancer Awareness Month. The risk of lung cancer can be reduced by quitting smoking and limiting exposure to secondhand smoke, environmental, and workplace risk factors. If you have concerns about your risk or because of your family history, it is important to discuss this with your doctor.

November is Lung Cancer Awareness Month! Join us throughout the month and learn how you can support our efforts to raise awareness of the leading cancer killer and make a meaningful impact in the lives of those living with the disease. LUNGFORCE.org